Cite
Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Review of Current Status
MLA
Alan Tyndall. “Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Review of Current Status.” BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 33, no. 4, July 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....91043720d6d39c998312b5a61ad556cf&authtype=sso&custid=ns315887.
APA
Alan Tyndall. (2019). Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Review of Current Status. BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 33(4).
Chicago
Alan Tyndall. 2019. “Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Review of Current Status.” BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 33 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....91043720d6d39c998312b5a61ad556cf&authtype=sso&custid=ns315887.